News
2d
GlobalData on MSNNuvectis Pharma cuts NXP800 in ovarian cancer after early failureNuvectis Pharma is terminating development of NXP800 in ovarian cancer after it failed to show promise in a Phase Ia/Ib study ...
When it comes to cancer, the early symptoms are so generic and mild, that most people brush them away as regular tiredness or fatigue, especially if cancer does not run in the family. However, some ...
High-risk factors for endometrial or uterine cancer were obesity, hypertension, and those who underwent hormone replacement ...
According to SNS Insider, Global Ovarian Cancer Diagnostics Market Growth is Driven by Rising Awareness, Technological Advancements in Imaging & Biomarker.Austin, Aug. 04, 2025 (GLOBE NEWSWIRE) -- ...
Investigators discuss how their findings on ovarian cancer mortality trends can guide earlier detection and prevention ...
CHENNAI: Apollo Cancer Centre (ACC) and Apollo Proton Cancer Centre (APCC) have launched ‘End-O Check’, a specialised ...
O Check,’ a targeted early detection initiative aimed at women aged 45 and above. The program emphasizes screening for endometrial and ovarian cancers through awareness, proactive diagnostics like ...
It's regarded as a waste product, but new technology means menstrual blood could be used to monitor signs of diseases ...
Endometriosis doesn't always scream signs. Discover the challenges of asymptomatic endometriosis, its potential risks, and ways to protect reproductive health.
Breast cancer is the most prevalent and dreaded cancer in all women in the world. There is also cervical, ovarian, ...
Generally, type 2 diabetes is associated with insulin resistance from a poor diet, a sedentary lifestyle, and unhealthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results